Skip to main content
Midas Edge

CODEXIS INC

For the period ended Sep 30, 2024. Filed Oct 31, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Oct 31, 2024

CDXS$1.11+2.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Condensed Consolidated Statements of Stockholders' Equity

Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Income (Loss) · Accumulated Deficit · Total Stockholders' Equity
Three Months Ended September 30, 2024 · Shares · Amount
Balance as of July 1, 202470,914$7$593,253$(23)$(531,790)$61,447
Issuance of common stock upon release of stock awards22—————
Issuance of common stock in connection with an equity sales agreement, net of issuance costs of $1,58410,440129,735——29,736
Stock-based compensation——2,708——2,708
Net Loss————(20,640)(20,640)
Other comprehensive gain———149—149
Balance as of September 30, 202481,376$8$625,696$126$(552,430)$73,400
Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Income · Accumulated Deficit · Total Stockholders' Equity
Three Months Ended September 30, 2023 · Shares · Amount
Balance as of July 1, 202369,804$6$579,555$—$(455,430)$124,131
Issuance of common stock upon release of stock awards23—————
Stock-based compensation——2,283——2,283
Net Loss————(34,908)(34,908)
Balance as of September 30, 202369,827$6$581,838$—$(490,338)$91,506

Condensed Consolidated Statements of Stockholders' Equity

Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Income · Accumulated Deficit · Total Stockholders' Equity
Nine Months Ended September 30, 2024 · Shares · Amount
Balance as of January 1, 202469,905$7$584,138$—$(497,530)$86,615
Issuance of common stock upon exercise of stock options73—143——143
Issuance of common stock upon release of stock awards834—————
Issuance of common stock warrants in connection with debt issuance——859——859
Issuance of common stock under employee stock purchase plan124—260——260
Issuance of common stock in connection with an equity sales agreement, net of issuance costs of $1,58410,440129,735——29,736
Stock-based compensation——10,561——10,561
Net Loss———(54,900)(54,900)
Other comprehensive gain———126—126
Balance as of September 30, 202481,376$8$625,696$126$(552,430)$73,400
Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Income · Accumulated Deficit · Total Stockholders' Equity
Nine Months Ended September 30, 2023 · Shares · Amount
Balance as of January 1, 202365,811$6$566,081$—$(421,290)$144,797
Issuance of common stock upon exercise of stock options214—422——422
Issuance of common stock upon release of stock awards787—————
Issuance of common stock in connection with an equity sales agreement, net of issuance costs of $7213,080—7,931——7,931
Stock-based compensation——7,808——7,808
Taxes paid related to net share settlement of equity awards(65)—(404)——(404)
Net Loss————(69,048)(69,048)
Balance as of September 30, 202369,827$6$581,838$—$(490,338)$91,506
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.